462 Pre-selection of patients who would respond to combination of chemotherapy and low dose immunotherapy using human histoculture platform

• Satish Sankaran,
• BV Prakash,
• MS Ganesh,
• Amritha Prabha,
• Kowshik Jaganathan,
• M Rajashekar,
• Ritu Malhotra,
• M Oliyarasi,
• Biswajit Das,
• Vijay Pillai,
• Ravi Krishnappa,
• V Syamkumar,
• Chandan Bhowal,
• M Mouniss,
• M Dharanidharan,
• K Govindraj,
• Manjunath I Nandennavar,
• Shashidhar V Karpurmath,
• Mohit Malhotra,
• Nandini P Basak

Affiliations

Satish Sankaran

1Farcast Biosciences, Bangalore, India

BV Prakash

2Sri Lakshmi Multi Speciality Hospital, Bangalore, India

MS Ganesh

4Vydehi Multi Speciality Hospital, Bangalore, India

Amritha Prabha

4Vydehi Multi Speciality Hospital, Bangalore, India

Kowshik Jaganathan

1Farcast BioSciences Pvt Ltd, Bangalore, India

M Rajashekar

1Farcast BioSciences Pvt Ltd, Bangalore, India

Ritu Malhotra

1Farcast Biosciences, Bangalore, Karnataka, India

M Oliyarasi

1Farcast BioSciences Pvt Ltd, Bangalore, India

Biswajit Das

1Farcast Biosciences, Bangalore, India

Vijay Pillai

4Mazumdar Shaw Medical Center Narayana Health, Bangalore, India

Ravi Krishnappa

5JSS hospital, Mysore, Karnataka, India

V Syamkumar

1Farcast Biosciences, Bangalore, Karnataka, India

Chandan Bhowal

1Farcast Biosciences, Bangalore, Karnataka, India

M Mouniss

1Farcast Biosciences, Bangalore, Karnataka, India

M Dharanidharan

1Farcast Biosciences, Bangalore, Karnataka, India

K Govindraj

1Farcast Biosciences, Bangalore, Karnataka, India

Manjunath I Nandennavar

4Mazumdar Shaw Medical Center Narayana Health, Bangalore, India

Shashidhar V Karpurmath

3Vydehi Multi Speciality Hospital, Bangalore, Karnataka, India

Mohit Malhotra

6Farcast Biosciences, LLC, Pensacola, FL, USA

Nandini P Basak

1Farcast Biosciences, Bangalore, Karnataka, India